News
Acute kidney injury in children hospitalized with diarrheal illness in the U.S.
April 29, 2020
Diarrheal illness is the fourth leading cause of death for children younger than 5 years and the fifth leading cause of years of life lost globally.
News
Dapagliflozin trial in CKD halted because of high efficacy
March 30, 2020
An independent data monitoring committee recommended stopping the trial.
News
Children with resistant UTIs unexpectedly may respond to discordant antibiotics
January 17, 2020
A low rate of care escalation and high rate of clinical improvement suggest this may be a reasonable approach until urine culture sensitivities return.
Article
FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections
November 15, 2019
The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate.
News
New model for CKD risk draws on clinical, demographic factors
November 8, 2019
The equation has demonstrated high discrimination and variable calibration across a range of populations.
News
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
September 30, 2019
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
News
Type of renal dysfunction affects liver cirrhosis mortality risk
September 4, 2019
Patients with acute on chronic kidney disease fared the worst.
News
Anticoagulant therapy for AFib in patients with end-stage renal disease
August 23, 2019
Apixaban may be safer than warfarin for patients who have ESRD and who plan for anticoagulation because of AFib.
News
NOACs benefit early stage chronic kidney disease patients
July 15, 2019
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
News
What’s new in pediatric sepsis
June 26, 2019
LJUBLJANA, SLOVENIA – Don’t obsess about “Golden Hour” for delivering sepsis treatment bundle, expert advises.